EMA committee recommends six medicines for approval
The October CHMP highlights include recommendations across oncology, metabolic disease and biosimilars.
Read the EMA report ↗PHARMA INTELLIGENCE / PRODUCTS / CDMO
Follow the developments shaping medicines and manufacturing, then explore products and the partners behind your next project.
REGULATORY HIGHLIGHT
The CHMP issued positive opinions for six medicines; recommendations are subject to a European Commission decision.
THE LATEST / PHARMA INTELLIGENCE
The October CHMP highlights include recommendations across oncology, metabolic disease and biosimilars.
Read the EMA report ↗The FDA's notable approvals list records its decision for Awiqli on October 23.
View the FDA list ↗Understand the questions to ask about process knowledge, quality systems and technology transfer.
Read the guide ↗01 / SELECTED FOCUS

Selected molecules and process needs requiring focused scale-up or sourcing.
Discuss project fit ↗Projects where containment, occupational safety and facility fit matter.
Discuss project fit ↗Early evaluation of specialist manufacturing and supply-chain requirements.
Discuss project fit ↗02 / HOW WE HELP
A focused bridge between international requirements and China's pharmaceutical manufacturing ecosystem.
Start a conversation ↗
Identify selected APIs, intermediates and specialty products against clear demand and quality needs.
Connect projects with relevant process, scale, containment and regulatory capabilities.
Structure partner research and qualification questions before commercial discussions.
Track representative, high-barrier technologies and products with industrial potential.
04 / YOUR REQUIREMENT
Share a few details. Your email application will open addressed to our team at info@lentotech.com.
LentoTech is building an intelligence-led platform for pharmaceutical products, specialist manufacturing and cross-border collaboration.
info@lentotech.com ↗